🇺🇸 FDA
Patent

US 8445461

Pharmaceutical composition for meniere's disease

granted A61KA61K31/047A61K31/702

Quick answer

US patent 8445461 (Pharmaceutical composition for meniere's disease) held by Setsuko Takeda expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Setsuko Takeda
Grant date
Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/047, A61K31/702, A61K31/715, A61K31/717